CorMedix (CRMD) Tax Provisions (2011 - 2026)
CorMedix (CRMD) posted Tax Provisions of $68.2 million for Q4 2025, up 221.86% sequentially from -$56.0 million in Q3 2025, and up 29662402.17% YoY from N/an in Q4 2024.
CorMedix (CRMD) Tax Provisions (2011 - 2026) Analysis & Trends
CorMedix has reported Tax Provisions for 9 years, with the latest figure at $68.2 million in Q4 2025.
- Quarterly Tax Provisions rose 29662402.17% year-over-year to $68.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (up 1014.54% YoY) and the FY2025 annual result came in at $12.8 million, up 1014.55% from the prior year.
- Tax Provisions grew to $68.2 million in Q4 2025 per CRMD's latest filing, from -$56.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $68.2 million in Q4 2025 and troughed at -$56.0 million in Q3 2025.
- A 4-year average of $1.1 million and a median of -$2730.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 29662402.17% in 2025, down 1070593.35% in 2025.
- Over 4 years, Tax Provisions stood at $1.9 million in 2021, then sank by 131.21% to -$585617.0 in 2022, then jumped by 99.96% to -$230.0 in 2024, then jumped by 29662402.17% to $68.2 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $68.2 million, -$56.0 million, and $521507.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 12.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.75 Mn |
| Dec 31, 2025 | 68.22 Mn |
| Sep 30, 2025 | -55.99 Mn |
| Jun 30, 2025 | 521,507.00 |
| Dec 31, 2024 | -230.00 |
| Sep 30, 2024 | 5,230.00 |
| Jun 30, 2024 | -5,230.00 |
| Mar 31, 2024 | -1.39 Mn |
| Jun 30, 2022 | -585,617.00 |
| Dec 31, 2021 | 1.88 Mn |
| Jun 30, 2021 | -1.25 Mn |
| Dec 31, 2020 | 6.51 Mn |
| Jun 30, 2020 | -5.17 Mn |
| Dec 31, 2019 | 11.08 Mn |
| Jun 30, 2019 | -5.06 Mn |
| Dec 31, 2016 | 2.00 |
| Sep 30, 2016 | 7.00 |
| Jun 30, 2016 | 3.00 |
| Mar 31, 2016 | -31.00 |
| Dec 31, 2015 | 38.00 |